All In MedTech

Device Trial Radar · NCT03012776

A Pivotal Study of the Premia Spine TOPS™ System

A Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS™ System

Last checked: Nov 19, 2026Latest source record: Jun 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingTitle says "pivotal". Randomized with 305 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

305

Actual

Start

Jul 17, 2017

Primary completion

Jun 27, 2022

Study completion Jun 14, 2023

Sponsor

Lead sponsor
Premia SpineNot on our public-company list
Sponsor type
Industry
First posted
Jan 6, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 35 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to assess whether the Total Posterior Spine System (TOPS System) is more effective than transforaminal lumbar interbody fusion (TLIF) when used to stabilize a single lumbar level (L2 - L5) following surgical decompression in patients diagnosed with (1) at least moderate lumbar spinal stenosis, and (2) Grade 1 spondylolisthesis (or retrolisthesis), and (3) thickening of the ligamentum flavum or scarring of the facet joint capsule. Success will be assessed by means of a composite endpoint that measures improvement in in patient reported outcomes and the absence of any major device related complications.

Conditions

  • Lumbar Spinal Stenosis
  • Degenerative Spondylolisthesis

Interventions

  • Total Posterior Spine System (TOPS)Device

    Placement of TOPS System to provide posterior stabilization following decompression to treat lumbar spinal stenosis and spondylolisthesis

  • Transforaminal Lumbar Interbody Fusion (TLIF)Procedure

    Fusion with placement of interbody cage and posterolateral instrumentation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement in Oswestry Disability Index (ODI)Time frame: 24 months
  2. Maintenance or improvement in Neurological status as assessed by a standard neurological exam performed by InvestigatorTime frame: 24 months
  3. No epidural steroid injection, facet joint injection, nerve block, or placement of spinal cord stimulatorTime frame: 24 months

3 more outcomes with a free account

Locations

36 sites in 1 country. Site status is shown where the registry gives one.

  • Adventist Health Glendale

    Glendale, California

  • Cedars Sinai

    Los Angeles, California

  • University of California - Irvine Medical Center

    Orange, California

33 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.